Pelthos Therapeutics Inc.
New Filing
CIK: 0001919246·Pharmaceuticals·NEVADA·Filed: Nov 16, 2026
Total Offering
$57,500,000
Amount Sold
$57,500,000
Investors
7
First Sale
Oct 30, 2026
Offering Details
- Type
- Equity, Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Scott Plesha | Related Person |
| John M. Gay | Related Person |
| Sai Rangarao | Related Person |
| Richard Baxter | Related Person |
| Peter Greenleaf | Related Person |
| Ezra Friedberg | Related Person |
| Todd Davis | Related Person |
| Richard Malamut | Related Person |
| Matthew Pauls | Related Person |
| Andrew Einhorn | Related Person |
Company
SEC Filing
0001919246-26-000142
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free